Disease Mongering (Pseudo-Disease Promotion)
Analiżi fil-Fond
15-11-2012
Disease mongering is the promotion of pseudo-diseases by the pharmaceutical industry aiming at economic benefit. Medical equipment manufacturers, insurance companies, doctors or patient groups may also use it for monetary gain or influence. It has increased in parallel with society's 'medicalisation' and the growth of the pharmaceutical complex. Due to massive investments in marketing and lobbying, ample use of internet and media, and the emergence of new markets, it is becoming a matter of concern, and policy makers should be aware of its perils and consequences.
Analiżi fil-Fond
Dwar dan id-dokument
Tip ta’ pubblikazzjoni
Qasam tematiku
Kelma għat-tiftix
- IMPJIEGI U KUNDIZZJONIJIET TAX-XOGĦOL
- industrija farmaċewtika
- istituzzjonijiet tal-UE u servizz ċivili Ewropew
- konsum
- KUMMERĊ
- kunflitt ta' interess
- KWISTJONIJIET SOĊJALI
- l-Aġenzija Ewropea għall-Mediċini
- liġi tax-xogħol u relazzjonijiet industrijali
- prevenzjoni tal-mard
- prodott farmaċewtiku
- protezzjoni tal-konsumatur
- saħħa
- saħħa pubblika
- servizz tas-saħħa
- UNJONI EWROPEA